Citations

Showing 10 of 107940 citations.

Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma
Reeder, Craig B. , Reece, Donna , Kukreti, Vishal , Chen, Christine , Trudel, Suzanne , Laumann, Kristina, Hentz, Joseph G. , Pirooz, Nicholas, Píza, J, Tiedemann, Rodger E. , Bergsagel, P. Leif , Leis, José F., Fonseca, Rafaël , Stewart, Alexander K., Mıkhael, Joseph , Bergsagel, P. Leif , Fonseca, Rafael

Mayo Clinic

Blood | April 22, 2010 | Volume: 115 | Issue: 16 | Pages: 3416-3417

10.1182/blood-2010-02-271676 | PMID 20413666 Get It

Manofluorographic and functional outcomes after endoscopic laser cricopharyngeal myotomy for cricopharyngeal bar
Özgürsoy, Ozan Bağış , Salassa, John R.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | April 22, 2010 | Volume: 142 | Issue: 5 | Pages: 735-740

10.1016/j.otohns.2009.08.020 | PMID 20416465 Get It

ObjectiveTo investigate the manofluorographic and functional outcomes after endoscopic laser cricopharyngeal myotomy (ELCPM) for cricopharyngeal (CP) bar.Study DesignCase series with chart review.SettingAcademic medical center.Subjects and MethodsReview of patients undergoing ELCPM between 2001 and 2007 was undertaken to determine the demographic, clinical, and manofluorographic findings before and six months after surgery. Two groups were established according to pharyngeal driving pressures: normal pressure group (> 55 mm Hg) and low pressure group (< 55 mm Hg).ResultsFourteen patients underwent ELCPM for CP bar without a concomitant head and neck or Zenker's procedure. There were no major surgical complications. All 14 patients improved at least one stage on the Functional Outcome Swallowing Scale (FOSS) after surgery. There was a statistically significant decrease in the FOSS stages after surgery. Videofluoroscopy demonstrated a significant postoperative increase in the mean cross‐sectional CP opening (CP‐area) from 32.75 to 123.52 mm2. Manofluorographic pressure recordings showed a significant postoperative decrease in the intrabolus pressure gradient across the cricopharyngeal region (IB‐Gra) from 25.44 to 13.22 mm Hg. Despite significant overall results, the change in the IB‐Gra showed no difference between the patient groups.ConclusionSubjective (FOSS) and objective manofluorographic (CP‐area, IB‐Gra) improvement in CP bar patients occurred after ELCPM. We suggest IB‐Gra as a reliable objective indicator for patients who might benefit from ELCPM and as an appropriate parameter for follow‐up after surgery. However, continued research on a larger patient population is required to enhance our understanding of CP bar and predictors of outcome after treatment of CP bar dysphagia.
Dose-response downregulation within the span of single interpulse intervals
Keenan, Daniel M., Roelfsema, Ferdinand , Veldhuis, Johannes D.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | April 21, 2010 | Volume: 299 | Issue: 1 | Pages: R11-R18

10.1152/ajpregu.00201.2010 | PMID 20410472 Get It

Pituitary ACTH drives adrenal glucocorticoid (cortisol) pulses via a time-delayed asymptotic dose-response process. To test the postulate that ACTH stimulates cortisol secretion dynamically (unequally during the initiation and termination of a cortisol secretory burst), a mathematical formalism was developed in which dose-response hysteretic shifts were allowed, but not required, within the time evolution of ACTH-cortisol pulse pairs. A dual-waveform deconvolution model was used to quantify cortisol secretion rates and reconstruct ACTH concentration profiles in 28 healthy adults previously sampled every 10 min for 24 h in the unstressed state (8,120 measurements). ACTH concentration-cortisol secretion dose-response functions were then estimated in each subject 1) without hysteresis (base model) and with allowances for possible hysteresis in 2) ACTH potency, 3) adrenal sensitivity, and 4) ACTH efficacy. Model residual error was 40% lower in the potency and sensitivity models and 20% lower in the efficacy model than in the base model ( P < 0.001). Mean time shifts for inferable hysteretic inflection were model-independent, i.e., grand mean (95% confidence interval) 22 (12–39) min after the onset of a cortisol secretory burst. Half-maximally effective ACTH concentrations (EC50) differed before and after hysteretic inflection within individual pulses: 1) 9.4 and 54 ng/l in the potency model ( P < 0.001) and 2) 8.9 and 123 ng/l in the sensitivity model ( P < 0.001) compared with 16 ng/l in the no-hysteresis model ( P < 0.001). In the efficacy-shift model, estimated maximal ACTH drive varied by 17-fold within cortisol secretory bursts (from 22 to 1.3 nmol·l−1·min cortisol secretion−1, P < 0.001). The collective results introduce the basis for modeling the dynamics of rapid, reversible physiological downregulation within the span of single interpulse intervals in vivo. This construct should have utility in parsing mechanisms of physiological regulation in other integrative systems.
Case series of sixteen patients with nummular headache
Moon, Justin S., Garza, Ivan , Ahmed, Kamran A.

Mayo Clinic

Cephalalgia | April 21, 2010 | Volume: 30 | Issue: 12 | Pages: 1527-1530

10.1177/0333102410368445 | PMID 20974606 Get It

Introduction: Nummular headache is a rare primary headache disorder described by a focal circumscribed area of pain (2–6 cm in diameter). Literature on this disorder is sparse. Patients and methods: Here, we describe a case series of 16 patients (6 men, 10 women) seen at the Mayo Clinic. Results: Mean age of onset was 50 years (range, 19–79 years) and mean duration of headache was 7.9 years (range, 0.33–40 years). Location of headache varied and was found to be an average of 3.9 cm in diameter (range, 2–10 cm). Headache was episodic (<15 days/month) in four patients and chronic (>15 days/month) in 12 patients. Attention was paid to therapeutic interventions. Resolution was seen in 38% of patients. Migraine was present in the history of 56% of patients and medication overuse headache was found in 25%. Conclusions: Our series results support previous findings. In our population, no specific therapy was identified to be effective in more than one patient.
Reply
Fidler, Jeff L. , Huprich, James E., Bruining, David H. , Fidler, Jeff L. , Fletcher, Joel G.

Mayo Clinic

American Journal of Roentgenology | April 21, 2010 | Volume: 194 | Issue: 5 | Pages: W458-W458

10.2214/ajr.09.3877 Get It

Musculoskeletal Trauma Simplified: A Casebook to Aid Diagnosis and Management.
Foreman, Kristopher

Mayo Clinic

American Journal of Roentgenology | April 21, 2010 | Volume: 194 | Issue: 5 | Pages: W456-W456

10.2214/ajr.09.3831 Get It

Adenoid Cystic Carcinoma of the Breast
Glazebrook, Katrina N. , Reynolds, Carol, Smith, Robin L., Gimenez, Edgardo I., Boughey, Judy C.

Mayo Clinic

American Journal of Roentgenology | April 21, 2010 | Volume: 194 | Issue: 5 | Pages: 1391-1396

10.2214/ajr.09.3545 | PMID 20410430 Get It

New-generation 5-HT4receptor agonists: potential for treatment of gastrointestinal motility disorders
Manabe, Noriaki , Wong, Banny S., Camilleri, Michael

Mayo Clinic

Expert Opinion on Investigational Drugs | April 21, 2010 | Volume: 19 | Issue: 6 | Pages: 765-775

10.1517/13543784.2010.482927 | PMID 20408739 Get It

Role ofN-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor
Dong, Maoqing , Chen, Quan , Miller, Laurence J.

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | April 21, 2010 | Volume: 299 | Issue: 1 | Pages: E62-E68

10.1152/ajpendo.00067.2010 | PMID 20407008 Get It

The family B G protein-coupled glucagon-like peptide 1 (GLP-1) receptor is an important drug target for treatment of type 2 diabetes. Like other family members, the GLP-1 receptor is a glycosylated membrane protein that contains three potential sites for N-linked glycosylation within the functionally important extracellular amino-terminal domain. However, the roles for each potential site of glycosylation in receptor biosynthesis, trafficking, and function are not known. In this work, we demonstrated that tunicamycin inhibition of glycosylation of the GLP-1 receptor expressed in CHO cells interfered with biosynthesis and intracellular trafficking, thereby eliminating natural ligand binding. To further investigate the roles of each of the glycosylation sites, site-directed mutagenesis was performed to eliminate these sites individually and in aggregate. Our results showed that mutation of each of the glycosylation sites individually did not interfere with receptor expression on the cell surface, ligand binding, and biological activity. However, simultaneous mutation of two or three glycosylation sites resulted in almost complete loss of GLP-1 binding and severely impaired biological activity. Immunostaining studies demonstrated receptor biosynthesis but aberrant trafficking, with most of the receptor trapped in the endoplasmic reticulum and golgi compartments and little of the receptor expressed on the cell surface. Interestingly, surface expression, ligand binding, and biological activity of these mutants improved significantly when biosynthesis was slowed using low temperature (30°C). These data suggest that N-linked glycosylation of the GLP-1 receptor is important for its normal folding and trafficking to the cell surface.
Randomized Phase II Trials: Inevitable or Inadvisable?
Gan, Hui , Grothey, Axel, Pond, Gregory R. , Moore, Malcolm J. , Sargent, Daniel J. , Siu, Lillian L. , Sargent, Daniel J , Pond, Gregory Russell

Mayo Clinic

Journal of Clinical Oncology | April 21, 2010 | Volume: 28 | Issue: 15 | Pages: 2641-2647

10.1200/jco.2009.26.3343 | PMID 20406933 Get It